Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Funding & investments

Home » Funding & investments

Beam Therapeutics Announces Closing of Initial Public Offering

February 11, 2020 07:41 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing...

Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market

Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics

Expands strategic partnerships with AnGes and Takeda Accelerates novel OMNI gene editing platform into a broad therapeutic product pipeline January 15, 2020 06:00 AM Eastern Standard Time NEW YORK–(BUSINESS...

Dominic Borie

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products

AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

DMC Biotech Total Series A Fundraising Closes With $11.3 Million

NovoNutrients Joins Chevron Technology Ventures’ Catalyst Program

business

Ask a VC

Turbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug Discovery

X-37 Announces $14.5 Million Series A

Linear Diagnostics

University of Birmingham spin-out secures £2m to develop medical diagnostic technology

eGenesis Announces $100 Million Series B Financing

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases

TetraScience secures investment from Waters Corporation, joining Floodgate Capital, First Round, Underscore VC, Founder Collective and Y Combinator in $8M series A